Experimental measles: II. Infection and immunity in the rhesus macaque

Virology

Volumn 233, Issue 1, 1997, Pages 85-92

  Zhu, Yong De ^a   Heath, Janet ^b   Collins, Jennifer ^a   Greene, Todd ^a   Antipa, Linda ^a   Rota, Paul ^b   Bellini, William ^b   McChesney, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOID TISSUE; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VIREMIA; VIRUS INFECTION; VIRUS TITRATION;

ANIMALIA; MACACA MULATTA; MEASLES VIRUS;

EID: 0030876558     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8575     Document Type: Article

References (44)

1. Albrecht P., Herrmann K., Burns G. R. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods. 3:1981;251-260.
2. Anderson L., Hierholzer J., Bingham P., Stone Y. Microneutralization test for respiatory syncytial virus based on an enzyme immunoassay. J. Clin. Microbiol. 22:1985;1050-1052.
3. Anderson R. M., May R. M. Vaccination and herd immunity to infectious diseases. Nature. 318:1985;323-329.
4. Bellini W., Englund G., Rammohan K., McFarlin D. Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies. J. Neuroimmunol. 11:1986;19-163.
5. Blake F. G., Trask J. D. Studies on measles. I. Susceptibility of monkeys to the virus of measles. J. Exp. Med. 33:1921a;385-413.
6. Blake F. G., Trask J. D. Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected. J. Exp. Med. 33:1921b;413-422.
7. Blake F. G., Trask J. D. Studies on measles. III. Acquired immunity following experimental measles. J. Exp. Med. 33:1921c;621-626.
8. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21:1968;77-89.
9. Burnet F. M. Measles as an index of immunological function. Lancet. II:1968;610-613.
10. Christenson B., Bottiger M. Measles antibody: Comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 12:1994;129-133.
11. Cohn M. L., Robinson E. D., Faerber M., Thomas D., Geyer S., Peters S., Martin M., Martin A., Sobel D., Jones R., Larkin L., Richert J. R. Measles vaccine failures: Lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults. Pediatr. Infect. Dis. J. 13:1994;34-38.
12. Cutts F. T., Markowitz L. E. Successes and failures in measles control. J. Infect. Dis. 1994;S32-S41.
13. Eghafona M., Ahmad A., Ezeokoli C., Emejuaiwe S. Haemaglutination inhibition antibody levels one year after natural measles infection and vaccination. Microbios. 68:1991;33-36.
14. Enders J., Katz S., Milovanovic M., Holloway A. Studies on an attenuated measles-virus vaccine. N. Engl. J. Med. 263:1960;153-159.
15. Erdman D., Anderson L., Adams D., Stewart J., Markowitz L., Bellini W. Evaluation of monoclonal antibody-based capture enzyme immuno-assay for detection of specific antibodies to measles virus. J. Clin. Microbiol. 20:1991;2874-2880.
16. Good R., Zak S. Disturbances in gammaglobulin synthesis as "experiments of nature" Pediatrics. 18:1956;109-149.
17. Griffin D. E., Bellini W. J. Measles virus. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1267-1312.
18. Hicks J., Sullivan J., Albrecht P. Immune responses during measles infection in immunosuppressed rhesus monkeys. J. Immunol. 119:1977;1452-1456.
19. Hilleman M. R. Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. Aids Res. Hum. Retroviruses. 10:1994;3-12.
20. Hummel K. B., Erdman D. D., Heath J., Bellini W. J. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:1992;2874-2880.
21. Jacobson S., Richert J., Biddison W., Satinsky A., Hartzman R., McFarland H. Measles virus-specific human cytotoxic T cell clones are restricted by class II antigens. J. Immunol. 133:1984;754-757.
22. Jacobson S., Sekaly R. P., Jacobson C. L., McFarland H. F., Long E. O. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1989;1756-1762.
23. Kawahora J. Experimental pathology of measles in monkeys. Jpn. J. Med. Sci. Biol. 18:1965;51-52.
24. Kobune F., Sakata H., Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:1990;700-705.
25. Kobune F., Takahashi H., Terao K., Ohkawa T., Ami Y., Suzaki Y., Nagata N., Sakata H., Yamanouchi K., Kai C. Nonhuman primate models of measles. Lab. Animal Sci. 46:1996;315-320.
26. Lohman B. L., McChesney M. B., Miller C. J., McGowan E., Joye S. M., Van Rompay K. K. A., Reay E., Antipa L., Pedersen N. C., Marthas M. L. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:1994;7021-7029.
27. Markowitz L., Albrecht P., Orenstein W., Lett S., Pugliese T., Farrell D. Persistence of measles antibody after revaccination. J. Infect. Dis. 166:1992;205-208.
28. McChesney M. B., Fujinami R. S., Lerche N. W., Marx P. A., Oldstone M. B. Virus-induced immunosuppression: Infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J. Infect. Dis. 159:1989;757-760.
29. McChesney M. B., Miller C. J., Rota P. A., Zhu Y., Antipa L., Lerche N. W., Ahmed R., Bellini W. J. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology. 233:1997;74-84.
30. Nanan R., Carstens C., Kreth H. Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation. Clin. Exp. Immunol. 102:1995;40-45.
31. Nii S., Kamahora J., Mori Y., Takahashi M., Nishimura S., Okuno Y. Experimental pathology of measles in monkeys. Biken J. 6:1964;271-297.
32. Norrby E. Measles vaccination, today and tomorrow. Ann. Inst. Pasteur/Virol. 136E:1985;561-570.
33. Norrby E., Oxman M. N. Measles virus. Fields B. N., Knipe D. M. Field's Virology. 1990;1013-1044 Raven Press, New York.
34. Peebles T. Distribution of virus in blood components during the viremia of measles. Arch. Ges. Virusforsch. 22:1967;43-47.
35. Reed L. J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hygiene. 27:1938;493-497.
36. Rota P. A., Bloom A. E., Vanchiere J. A., Bellini W. J. Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology. 198:1994;724-730.
37. Schwarz A., Boyer P., Zirbel L., York C. Experimental vaccination against measles. I. Test of live measles and distemper vaccine in monkey and two human volunteers under laboratory conditions. J. Am. Med. Assoc. 173:1960;861-867.
38. Snedecor G., Cochran W. Statistical Methods. 1967;Iowa State Univ. Press, Ames.
39. Van Baalen C. A., Klein M. R., Gereti A. M., Ket R. I. P. M., Miedema F., Van Els C. A. C. M., Osterhaus A. D. M. E. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: Cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS. 7:1993;781-786.
40. van Binnendijk R., van der Heijden R., van Amerongen G., UytdeHaag F., Osterhaus A. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J. Infect. Dis. 170:1994;443-448.
41. van Binnendijk R. S., Poelen M. C., Kuijpers K. C., Osterhaus A. D., Uytdehaag F. G. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. J. Immunol. 144:1990;2394-2399.
42. van Binnendijk R. S., Poelen M. C. M., de Vries P., Voorma H. O., Osterhaus A. D. M. E., Uytdehaag F. G. C. M. Measles virus-specifice human T cell clones: characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J. Immunol. 142:1989;2847-2854.
43. Wu V. H., McFarland H., Mayo K., Hanger L., Griffin D. E., Dhib Jalbut S. Measles virus-specific cellular immunity in patients with vaccine failure. J. Clin. Microbiol. 31:1993;118-122.
44. Yamanouchi K., Egashira Y., Uchida N., Kodama H., Kobune F., Hayami M., Fukuda A., Shishido A. Giant cell formation in lymphoid tissues of monkeys inoculated with various strains of measles virus. Jpn. J. Med. Sci. Biol. 23:1970;131-145.